Screener
Madrigal Pharmaceuticals, Inc. MDGL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s enterprise value?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported enterprise value of $12.46B in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s enterprise value increased by 98.7% year-over-year, from $6.27B to $12.46B.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s enterprise value has grown at a 48.6% compound annual growth rate (CAGR), from $1.85B to $13.37B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude